FDA Inspection 1257768 — LifeServe Blood Center

LifeServe Blood Center — FEI 1970355

The FDA completed an inspection of LifeServe Blood Center on November 22, 2024 in Johnston, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Johnston, IA (United States)